| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.8M | -21.3% |
| SG&A Expense | $1.3M | -13.1% |
| Operating Income | -$3.2M | +18.9% |
| Net Income | -$3.1M | +22.9% |
| EPS (Basic) | -$0.01 | +28.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41K | -80.6% |
| Current Assets | $77K | -69.9% |
| Total Assets | $1.0M | -6.8% |
| Current Liabilities | $1.5M | +135.3% |
| Total Liabilities | $4.6M | +32.6% |
| Stockholders' Equity | -$3.6M | -51.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.6M | +21.4% |
| Capital Expenditures | $288K | +108.3% |
| Investing Cash Flow | -$321K | -55.9% |
| Financing Cash Flow | $1.8M | +35.8% |
| Free Cash Flow | -$1.9M | +13.2% |